![]() Milo Biotechnology Milo Biotechnology is a mid-clinical-stage company developing drugs for multiple muscle wasting disorders. | WuXi Biologics WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development. | PPD PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions. | |||
Founding Date | Founding Date 2020 | Founding Date 2010 | Founding Date 2010 | Founding Date 1995 | Founding Date 1985 |
Type | Type Private | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Columbus, US HQ | Locations Cleveland, US HQ | Locations Wuxi, CN HQ George Town, KY Wuppertal, DE Hong Kong, HK Dundalk, IE Cranbury, US King Of Prussia, US | Locations Shanghai, CN HQ | Locations Wilmington, US HQ Buenos Aires, AR Melbourne, AU Brussels, BE Zaventem, BE São Paulo, BR São Paulo, BR see more |
Employees | Employees 3902% increase | Employees 1 | Employees 12,575 | Employees 8,989 | Employees 24,5842% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥21.8b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $4.7b (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥10b (FY, 2025) | Cost of goods N/A | Cost of goods $1.7b (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥12b (FY, 2025) | Gross profit N/A | Gross profit $3b (FY, 2020) |
Net income | Net income N/A | Net income N/A | Net income ¥5.7b (FY, 2025) | Net income N/A | Net income $160.6m (FY, 2020) |
Operating ⚠ | |||||
Backlog | Backlog N/A | Backlog N/A | Backlog $18.5b (H1, 2022) | Backlog N/A | Backlog $9.5b (Q3, 2021) |
Funding | |||||
Latest funding round | Latest funding round $ 120m (about 5 years ago) | Latest funding round $ 800k (over 9 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 160m | Total funding raised $ 1.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |

Milo Biotechnology is a mid-clinical-stage company developing drugs for multiple muscle wasting disorders.
View companyWuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
View company
Hansoh Pharmaceutical Group (翰森制药集团总) is a biopharmaceutical company.
View companyPPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions.
View company